ALPS Advisors’s Eikon Therapeutics EIKN Stock Holding History
Bought
Maintained
Sold
Other funds holding EIKN
ALPS Advisors's EIKN Position: Q3 2026 in Review
ALPS Advisors increased its Eikon Therapeutics (EIKN) stake by 30% in Q3 2026, buying an estimated $164K and bringing the position to 71,255 shares worth $573K. The position accounts for ﹤0.01% of the portfolio, ranked #874.
ALPS Advisors first reported a position in EIKN in Q2 2026 and has held it in 2 quarters since. The position peaked at $717K in Q2 2026. 98 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.
- ALPS Advisors held 71,255 shares of Eikon Therapeutics worth $573K as of Q3 2026.
- ALPS Advisors bought 16,307 Eikon Therapeutics shares in Q3 2026, an estimated $164K.
- Eikon Therapeutics made up ﹤0.01% of ALPS Advisors's portfolio in Q3 2026, its #874 holding.
- ALPS Advisors first reported a position in Eikon Therapeutics in Q2 2026 and has held it in 2 quarters since.
- ALPS Advisors's Eikon Therapeutics position peaked at $717K in Q2 2026.
- 98 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.
Based on ALPS Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.